4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-22-053357
Director bought 30,000 shares at $1.29 ($38,700)
From the SEC's structured data for this filing
Trades in this filing
Sukhtian Faisal Ghiath · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-07 | Purchase : show line 1 in the form | +30,000 | $1.29 | $38,700 | 68,000 | D |
| Open-market purchases · 30,000 sh · avg $1.29 · $38,700 | ||||||
Loading xslF345X03/doc4.xml…